amantadine has been researched along with Corneal Edema in 24 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Corneal Edema: An excessive amount of fluid in the cornea due to damage of the epithelium or endothelium causing decreased visual acuity.
Excerpt | Relevance | Reference |
---|---|---|
"Amantadine increases the risk of corneal edema in a dose-dependent manner." | 7.83 | Amantadine Use as a Risk Factor for Corneal Edema: A Nationwide Cohort Study in Taiwan. ( Chang, CH; Cheng, KC; Hsu, SL; Lee, PY; Lin, CC; Lin, CP; Tu, HP, 2016) |
"The authors report the successful use of Descemet's stripping automated endothelial keratoplasty (DSAEK) to treat a 45-year-old woman with amantadine-associated corneal edema." | 7.76 | Amantadine-associated corneal edema treated with descemet's stripping automated endothelial keratoplasty. ( Dupps, WJ; Hood, CT; Langston, RH; Schoenfield, LR, 2010) |
"With one exception, a case report of amantadine-induced corneal toxicity has described reversible corneal edema." | 7.75 | Nonimmunologic graft failure after Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for presumed amantadine-induced corneal edema. ( Koenig, SB; McDermott, ML; Simons, KB, 2009) |
"In this article, we report a case of bilateral severe reversible corneal edema caused by amantadine therapy." | 7.75 | Bilateral reversible corneal edema associated with amantadine use. ( Esquenazi, S, 2009) |
"To determine the proportion of patients who were dispensed amantadine and diagnosed with corneal edema or Fuchs dystrophy within specified time frames." | 7.74 | Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration. ( French, DD; Margo, CE, 2007) |
"To describe the clinical features of 3 patients with amantadine-associated corneal edema, including the histopathologic findings from 1 patient who underwent corneal transplantation for irreversible corneal edema." | 7.74 | Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. ( Galor, A; Hollyfield, JG; Jeng, BH; Langston, RH; Lee, MS; McMahon, JT; Meisler, DM; Schoenfield, L, 2008) |
"To document reversible corneal edema caused by amantadine in a pediatric patient." | 7.72 | Reversible amantadine-induced corneal edema in an adolescent. ( Brodsky, MC; Feiz, V; Flynn, SB; Hughes, B, 2004) |
"Amantadine was originally developed as an antiviral agent for influenza A." | 5.72 | Amantadine-induced bilateral corneal edema in a pediatric patient. ( Bohra, L; Chao, J; Dunn, S, 2022) |
"Corneal edema is a known but unusual side effect of amantadine therapy, rarely reported in the neurological literature." | 5.37 | Amantadine induced reversible corneal edema. ( Deogaonkar, M; Vitek, J; Wilson, K, 2011) |
"To report a case of a patient showing bilateral corneal opacities after amantadine chronic treatment for Parkinson's Disease (PD) and corneal edema associated with intra-epithelial and -endothelial depositions." | 4.12 | Amantadine therapy for Parkinson's Disease: In Vivo Confocal Microscopy corneal findings, case report and revision of literature. ( Cennamo, M; Dragotto, F; Favuzza, E; Mencucci, R; Morelli, A, 2022) |
"An adverse effect of amantadine, a drug used for Parkinson's disease, is corneal edema." | 3.91 | Effects of amantadine on corneal endothelium. ( Dudley, CE; Duffey, ME; Morell, AJ; Patel, SP, 2019) |
"Amantadine increases the risk of corneal edema in a dose-dependent manner." | 3.83 | Amantadine Use as a Risk Factor for Corneal Edema: A Nationwide Cohort Study in Taiwan. ( Chang, CH; Cheng, KC; Hsu, SL; Lee, PY; Lin, CC; Lin, CP; Tu, HP, 2016) |
"A 64 year-old female with Parkinson disease treated with amantadine for two years who suddenly suffered bilateral corneal oedema." | 3.78 | [Corneal toxicity due to amantadine]. ( Avendaño-Cantos, EM; Celis-Sánchez, J; Gálvez-Martínez, J; González Del Valle, F; López-Arroquia, E; Mesa-Varona, D, 2012) |
"Six eyes of 4 consecutive patients with clear crystalline lenses and corneal edema because of either Fuchs dystrophy (4 eyes) or amantadine-induced corneal endothelial toxicity (2 eyes) were included in this study." | 3.76 | Descemet stripping automated endothelial keratoplasty in the phakic eye. ( Koenig, SB, 2010) |
"The authors report the successful use of Descemet's stripping automated endothelial keratoplasty (DSAEK) to treat a 45-year-old woman with amantadine-associated corneal edema." | 3.76 | Amantadine-associated corneal edema treated with descemet's stripping automated endothelial keratoplasty. ( Dupps, WJ; Hood, CT; Langston, RH; Schoenfield, LR, 2010) |
"To describe bilateral corneal endothelial dysfunction in a patient with Parkinson disease who was treated with long-term amantadine." | 3.74 | Corneal endothelial dysfunction associated with amantadine toxicity. ( Chang, KC; Kim, MK; Lee, JH; Wee, WR, 2008) |
"To determine the proportion of patients who were dispensed amantadine and diagnosed with corneal edema or Fuchs dystrophy within specified time frames." | 3.74 | Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration. ( French, DD; Margo, CE, 2007) |
"To describe the clinical features of 3 patients with amantadine-associated corneal edema, including the histopathologic findings from 1 patient who underwent corneal transplantation for irreversible corneal edema." | 3.74 | Amantadine-associated corneal edema potentially irreversible even after cessation of the medication. ( Galor, A; Hollyfield, JG; Jeng, BH; Langston, RH; Lee, MS; McMahon, JT; Meisler, DM; Schoenfield, L, 2008) |
"Corneal edema is a known but unusual side effect of amantadine therapy, rarely reported in the neurological literature." | 1.37 | Amantadine induced reversible corneal edema. ( Deogaonkar, M; Vitek, J; Wilson, K, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.17) | 18.2507 |
2000's | 9 (37.50) | 29.6817 |
2010's | 12 (50.00) | 24.3611 |
2020's | 2 (8.33) | 2.80 |
Authors | Studies |
---|---|
Chao, J | 1 |
Dunn, S | 1 |
Bohra, L | 1 |
Cennamo, M | 1 |
Dragotto, F | 1 |
Favuzza, E | 1 |
Morelli, A | 1 |
Mencucci, R | 1 |
Beran, M | 1 |
Okyere, B | 1 |
Vova, J | 1 |
Dudley, CE | 1 |
Morell, AJ | 1 |
Duffey, ME | 1 |
Patel, SP | 1 |
Yang, Y | 1 |
Teja, S | 1 |
Baig, K | 1 |
Lee, PY | 1 |
Tu, HP | 1 |
Lin, CP | 1 |
Chang, CH | 1 |
Cheng, KC | 1 |
Lin, CC | 1 |
Hsu, SL | 1 |
Soin, K | 1 |
Feinstein, EG | 1 |
Guo, J | 1 |
Dubow, JS | 1 |
Rezak, M | 1 |
Berman, AA | 1 |
Chang, KC | 1 |
Kim, MK | 1 |
Wee, WR | 1 |
Lee, JH | 1 |
Pond, A | 1 |
Lee, MS | 2 |
Hardten, DR | 1 |
Harrison, AR | 1 |
Krachmer, JH | 1 |
Naumann, GO | 1 |
Schlötzer-Schrehardt, U | 1 |
Koenig, SB | 2 |
McDermott, ML | 1 |
Simons, KB | 1 |
Park, CY | 1 |
Chuck, RS | 1 |
Esquenazi, S | 1 |
Ghaffariyeh, A | 1 |
Honarpisheh, N | 1 |
Hood, CT | 1 |
Langston, RH | 2 |
Schoenfield, LR | 1 |
Dupps, WJ | 1 |
Deogaonkar, M | 1 |
Wilson, K | 1 |
Vitek, J | 1 |
Hotehama, A | 1 |
Mimura, T | 1 |
Usui, T | 1 |
Kawashima, H | 1 |
Amano, S | 1 |
Avendaño-Cantos, EM | 1 |
Celis-Sánchez, J | 1 |
Mesa-Varona, D | 1 |
Gálvez-Martínez, J | 1 |
López-Arroquia, E | 1 |
González Del Valle, F | 1 |
Hughes, B | 1 |
Feiz, V | 1 |
Flynn, SB | 1 |
Brodsky, MC | 1 |
French, DD | 1 |
Margo, CE | 1 |
Jeng, BH | 1 |
Galor, A | 1 |
Meisler, DM | 1 |
Hollyfield, JG | 1 |
Schoenfield, L | 1 |
McMahon, JT | 1 |
Blanchard, DL | 1 |
24 other studies available for amantadine and Corneal Edema
Article | Year |
---|---|
Amantadine-induced bilateral corneal edema in a pediatric patient.
Topics: Amantadine; Child; Corneal Edema; Humans | 2022 |
Amantadine therapy for Parkinson's Disease: In Vivo Confocal Microscopy corneal findings, case report and revision of literature.
Topics: Aged; Amantadine; Corneal Edema; Endothelial Cells; Humans; Male; Microscopy, Confocal; Parkinson Di | 2022 |
Amantadine-Induced Corneal Edema in a Pediatric Neuro-Oncology Patient: A Case Report.
Topics: Adolescent; Amantadine; Brain Neoplasms; Corneal Edema; Follow-Up Studies; Humans; Male; Neuroblasto | 2018 |
Effects of amantadine on corneal endothelium.
Topics: Amantadine; Animals; Apoptosis; Cattle; Corneal Edema; Dopamine Agents; Endothelium, Corneal; Ion Tr | 2019 |
Bilateral corneal edema associated with amantadine.
Topics: Amantadine; Corneal Edema; Corneal Pachymetry; Dopamine Agents; Humans; Male; Middle Aged; Slit Lamp | 2015 |
Amantadine Use as a Risk Factor for Corneal Edema: A Nationwide Cohort Study in Taiwan.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Corn | 2016 |
Recent-Onset Bilateral Blurred Vision.
Topics: Amantadine; Antiviral Agents; Corneal Edema; Corneal Pachymetry; Endothelium, Corneal; Female; Human | 2017 |
Reversible corneal edema associated with amantadine use: an unrecognized problem.
Topics: Aged; Amantadine; Antiparkinson Agents; Corneal Edema; Female; Humans; Movement Disorders | 2008 |
Corneal endothelial dysfunction associated with amantadine toxicity.
Topics: Administration, Oral; Amantadine; Antiparkinson Agents; Cell Count; Corneal Edema; Endothelium, Corn | 2008 |
Toxic corneal oedema associated with amantadine use.
Topics: Amantadine; Antiparkinson Agents; Child; Cornea; Corneal Edema; Female; Humans; Middle Aged; Parkins | 2009 |
Amantadine-associated corneal edema.
Topics: Amantadine; Analgesics, Non-Narcotic; Bipolar Disorder; Corneal Edema; Dopamine Agents; Humans; Kera | 2009 |
Nonimmunologic graft failure after Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for presumed amantadine-induced corneal edema.
Topics: Adult; Amantadine; Automation; Corneal Edema; Corneal Transplantation; Descemet Membrane; Drug Admin | 2009 |
Sudden bilateral corneal oedema in a patient with Parkinson's disease.
Topics: Adult; Amantadine; Antiparkinson Agents; Blindness; Corneal Edema; Functional Laterality; Humans; Ma | 2011 |
Bilateral reversible corneal edema associated with amantadine use.
Topics: Adult; Amantadine; Cornea; Corneal Edema; Diagnosis, Differential; Dopamine Agents; Female; Humans; | 2009 |
Descemet stripping automated endothelial keratoplasty in the phakic eye.
Topics: Adult; Amantadine; Cornea; Corneal Edema; Descemet Stripping Endothelial Keratoplasty; Female; Fuchs | 2010 |
Amantadine-associated corneal edema.
Topics: Aged; Amantadine; Anti-Inflammatory Agents; Antiparkinson Agents; Corneal Edema; Female; Humans; Oph | 2010 |
Amantadine-associated corneal edema treated with descemet's stripping automated endothelial keratoplasty.
Topics: Amantadine; Automation; Corneal Edema; Descemet Stripping Endothelial Keratoplasty; Diagnosis, Diffe | 2010 |
Amantadine induced reversible corneal edema.
Topics: Amantadine; Antiparkinson Agents; Corneal Edema; Female; Humans; Iatrogenic Disease; Middle Aged; Pa | 2011 |
Sudden onset of amantadine-induced reversible bilateral corneal edema in an elderly patient: case report and literature review.
Topics: Aged; Amantadine; Corneal Edema; Dopamine Agents; Endothelium, Corneal; Female; Functional Lateralit | 2011 |
[Corneal toxicity due to amantadine].
Topics: Acyclovir; Amantadine; Antiparkinson Agents; Aqueous Humor; Cataract Extraction; Ceftazidime; Cornea | 2012 |
Reversible amantadine-induced corneal edema in an adolescent.
Topics: Adolescent; Amantadine; Cornea; Corneal Edema; Dopamine Agents; Humans; Male; Visual Acuity | 2004 |
Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration.
Topics: Aged; Amantadine; Antiparkinson Agents; Antiviral Agents; Corneal Edema; Databases, Factual; Drug Pr | 2007 |
Amantadine-associated corneal edema potentially irreversible even after cessation of the medication.
Topics: Adult; Amantadine; Analgesics, Non-Narcotic; Bipolar Disorder; Corneal Edema; Dopamine Agents; Femal | 2008 |
Amantadine caused corneal edema.
Topics: Amantadine; Corneal Edema; Female; Humans; Middle Aged | 1990 |